Logo UHasselt

menu

Covid-19


All info about our research Covid-19

Covid-19

Logo UHasselt Universiteit Hasselt - Knowledge in action

EpiPose (referring to our efforts to ‘pause the epidemic’) and is the acronym for: Epidemic intelligence to minimize 2019-nCoV’s public health, economic and social impact in Europe

Funding acknowledgement

This project received funding (€ 2 933 912,50) from the European Union’s Research and Innovation Action under the H2020 work programme (grant agreement number ID: 101003688, https://cordis.europa.eu/project/id/101003688)

Consortium
Main expected outcomes
Project details
Scientific output and data
Contact details

Consortium

The consortium consists of 6 partners in 5 countries (BE, NL, UK, CH, IT) who provide complementary expertise in mathematical and statistical modelling of infectious diseases, participatory surveillance systems, living systematic reviews, and health economic analysis and have a strong international public health network.

The project is coordinated by Prof. Niel Hens and his team at UHasselt, Belgium

For more information about the participating organisations, please visit their websites:

top

Main expected outcomes

Outcome 1: increased social and behavioural insights and preparedness
We collect data on changes in people’s awareness, perceptions, social contacts and health condition during the course of the COVID-19 epidemic. This data is essential to assess efficiency of interventions and public health messaging and how people adhere to and cope with them.

Outcome 2: increased epidemiological insights and preparedness
We assess key epidemiological parameters in various countries and their change due to intervention measures through the development of robust statistical and mathematical models for epidemic nowcasting and forecasting.

Outcome 3: increased health and macro-economic insights and preparedness
We assess the COVID-19 disease burden, impact of the epidemic and intervention strategies on financial markets, economic transactions, health costs and other indicators and of cost-effectiveness of treatments when they become available.

top

Project details

EpiPose aims to provide urgently needed answers about the epidemiological characteristics of 2019-nCoV, the social dynamics of the outbreak, and the related public health preparedness and response to the ongoing epidemic, as well as to assess its economic impact. The consortium consists of 6 partners in 5 countries (BE, NL, UK, CH, IT) who provide complementary expertise in mathematical and statistical modelling of infectious diseases, participatory surveillance systems, living systematic reviews, and health economic analysis and have a strong international public health network. EpiPose aims at a quick delivery of results, according to the following objectives: 

  1. To collect and share epidemiological data of 2019-nCoV as widely as possible; 
  2. To provide country-specific estimates of key epidemiological parameters; 
  3. To model the expect impact of 2019-nCoV on morbidity and mortality; 
  4. To monitor awareness and behavioural change during the 2019-nCoV epidemic; 
  5. To provide health economic analyses for interventions within the EU; 
  6. To foster the interaction between the scientific community, public health agencies and the public EpiPose aims to make all research data, code, tools and results publicly available and its dissemination plan targets active communication and interaction with policy makers, other scientific groups and the general public. 

As such, the epidemic intelligence provided by EpiPose will help minimize the 2019-nCoV’s public health, economic and social impact.

top

 Scientific output and data

  • Data from the social contact and behavior survey in UK, NL and BE (possibly extended):
    Lead: LSHTM
    Link: www.socialcontacdata.org 

top

Contact details

dr. Sarah Vercruysse: sarah.vercruysse@uhasselt.be
dr. Bieke Vanhoutte: bieke.vanhoutte@uantwerpen.be
Follow us on Twitter: #EpiPose